Detalhe da pesquisa
1.
Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies.
BMC Med
; 21(1): 164, 2023 04 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37118803
2.
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trial.
Mol Cancer
; 21(1): 4, 2022 01 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34980131
3.
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial.
BMC Med
; 20(1): 42, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35101045
4.
Proteomic and metabolomic investigation of serum lactate dehydrogenase elevation in COVID-19 patients.
Proteomics
; 21(15): e2100002, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33987944
5.
High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma.
BMC Cancer
; 15: 687, 2015 Oct 13.
Artigo
Inglês
| MEDLINE | ID: mdl-26463718
6.
Pulmonary Adenocarcinoma Patient with Complex Mutations on EGFR Benefits from Furmonertinib after Acquiring Gefitinib Resistance: A Case Report.
Recent Pat Anticancer Drug Discov
; 19(2): 247-252, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38214361
7.
High-Throughput Sequencing to Investigate the Expression and Potential Role of Differentially Expressed microRNAs in Myocardial Cells after Ischemia-Reperfusion Injury.
Front Biosci (Landmark Ed)
; 29(1): 38, 2024 01 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38287811
8.
Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors.
Glob Med Genet
; 11(1): 86-99, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38414979
9.
A review on the current literature regarding the value of exosome miRNAs in various diseases.
Ann Med
; 55(1): 2232993, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37435923
10.
Case Report: Keratoacanthoma and type I diabetes secondary to treatment with PM8001, a bifunctional fusion protein targeting TGF-ß and PD-L1.
Front Oncol
; 13: 1046266, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37593095
11.
Efficacy and safety of re-challenging 160 mg furmonertinib for advanced NSCLC after resistance to third-generation EGFR-TKIs targeted agents: A real-world study.
Lung Cancer
; 184: 107346, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37604026
12.
Glucose metabolism profile recorded by flash glucose monitoring system in patients with hypopituitarism during prednisone replacement.
World J Diabetes
; 14(7): 1112-1125, 2023 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37547590
13.
Safety and efficacy of atezolizumab in Chinese patients with previously treated locally advanced or metastatic non-small cell lung cancer: An open-label, single-arm, multicenter study.
Lung Cancer
; 183: 107288, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37463531
14.
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study.
Lancet Respir Med
; 11(10): 905-915, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37244266
15.
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer.
Thorac Cancer
; 14(1): 91-104, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36444143
16.
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors.
Thorac Cancer
; 14(12): 1102-1117, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36924056
17.
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China.
Thorac Cancer
; 14(31): 3166-3177, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37718634
18.
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.
Thorac Cancer
; 14(26): 2715-2731, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37461124
19.
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01).
J Clin Oncol
; 41(3): 651-663, 2023 01 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36206498
20.
Current status and challenges of immunotherapy in ALK rearranged NSCLC.
Front Oncol
; 12: 1016869, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36591504